Gilead vs Mesoblast, page-31

First 31 Last

Share
Profile

Follow
vasilios

3,819 Posts.

359

18/04/20

10:31

Post #: 44114753
Share

Originally posted by Wazza222: ↑

My understanding of Remestemcel-L in the CV context is that it is for use with critically ill patients who have severe respiratory problems and likely already need a ventilator to survive.
The tests Gilead are doing are on severely ill patients (ie one step before critical). If their drug works,and patients walk out of hospital with no further respiratory complications - then suddenly there is no one in further need of critical care and thus our stem cells. This is where Gileads' drug is a threat to MSB - not that they are competing products but that theirs is preventing the disease progressing to the next stage.
There are still plenty of cases out there who are past the severe stage and hopefully MSB is the go to company to treat them. The recent anecdotal reports about remdesivir are premature to promote any success yet although it is one of these same "leaked glimpses" of the Mt Sinai trial that we are hanging out for ourselves.
@notbrad8 Your attempts to discredit the journalist despite his forthright follow up interview on CNBC seem unjustified. He appeared genuine and did not have to "back track" on the story he presented. He was doing his job - presenting some information that had come his way (a scoop or perhaps deliberately leaked).

Expand

The other way.

MSB Price at posting: $2.17 Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

MRC

Mineral Commodities to shut down Tormin mineral sands project as oil spill contaminates beach

MGU

New results confirm Buena Vista's iron grades potential

KOB

Koba, formerly a cobalt player, gears up to become newest explorer in the uranium state: South Australia

Trimmed CPI figure provokes market jump of 1%, but inflation pressures remain a reality

1CG

One Click Group jumps 4% after ending quarter with $2.4M in cash; $1M in revenue and 150K+ users on board

There are more pages in this discussion • 244 more messages in this thread...

First 31 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last $1.02		Change 0.015(1.49%)		Mkt cap ! $1.164B

Open	High	Low	Value	Volume
$1.00	$1.04	94.0¢	$11.76M	11.90M

Buyers (Bids)

No.	Vol.	Price($)
6	206912	$1.02

Sellers (Offers)

Price($)	Vol.	No.
$1.03	37637	1

View Market Depth

No.	Vol.	Price($)
6	206912	1.015
8	195410	1.010
5	95607	1.005
7	208096	1.000
3	103747	0.995

Price($)	Vol.	No.
1.025	37637	1
1.030	29757	2
1.035	91225	3
1.040	72457	5
1.045	126212	4

Last trade - 16.10pm 31/07/2024 (20 minute delay)

MSB (ASX) Chart

Gilead vs Mesoblast, page-31

Mineral Commodities to shut down Tormin mineral sands project as oil spill contaminates beach

New results confirm Buena Vista's iron grades potential

Koba, formerly a cobalt player, gears up to become newest explorer in the uranium state: South Australia

Trimmed CPI figure provokes market jump of 1%, but inflation pressures remain a reality

One Click Group jumps 4% after ending quarter with $2.4M in cash; $1M in revenue and 150K+ users on board

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Gilead vs Mesoblast, page-31

Top Stories

Mineral Commodities to shut down Tormin mineral sands project as oil spill contaminates beach

New results confirm Buena Vista's iron grades potential

Koba, formerly a cobalt player, gears up to become newest explorer in the uranium state: South Australia

Trimmed CPI figure provokes market jump of 1%, but inflation pressures remain a reality

One Click Group jumps 4% after ending quarter with $2.4M in cash; $1M in revenue and 150K+ users on board

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News